Key facts
- It has raised $11.8M across 3 recorded rounds; the latest was Seed Round ($580K) in Jun 2015.
- InNeuroCo has filed 3 Form Ds with the SEC since 2015, most recently Jun 2017 ($800K sold to 8 investors).
- Status: Acquired/Merged (Operating Subsidiary).
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for InNeuroCo
Funding rounds
3 roundsAbout InNeuroCo
Developer of neurovascular products designed to treat neurovascular diseases. The company's products give risk-free suction ability during the hemorrhagic stroke to clear the blockage and is indicated for the introduction of interventional devices into the peripheral and neuro vasculature, enabling doctors to operate on patients and fix the hemorrhage efficiently.
- Sector
- Healthcare
- HQ
- Pembroke Pines, FL, United States
- Founded
- 2014
- Employees
- 35
- Website
- inneuroco.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
InNeuroCo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InNeuroCo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InNeuroCo in its N-PORT filings yet. We sweep new filings monthly.